Pharmaceutical formulations comprising Se-methionine in amounts between 10 and 400 ug and inositol in amounts between 100 and 4000 mg are described.L'invention concerne des formulations pharmaceutiques comprenant de la Se-méthionine en quantités comprises entre 10 et 400 µg et de l'inositol en quantités comprises entre 100 et 4000 mg.